BEELINE HOLDINGS INC (BLNE) Fundamental Analysis & Valuation

NASDAQ:BLNE • US2778025005

Current stock price

1.93 USD
+0.16 (+9.04%)
At close:
1.93 USD
0 (0%)
After Hours:

This BLNE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BLNE Profitability Analysis

1.1 Basic Checks

  • BLNE had negative earnings in the past year.
  • BLNE had a negative operating cash flow in the past year.
  • BLNE had negative earnings in each of the past 5 years.
  • BLNE had a negative operating cash flow in each of the past 5 years.
BLNE Yearly Net Income VS EBIT VS OCF VS FCFBLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

  • BLNE's Return On Assets of -44.88% is on the low side compared to the rest of the industry. BLNE is outperformed by 92.00% of its industry peers.
  • The Return On Equity of BLNE (-58.78%) is worse than 87.00% of its industry peers.
Industry RankSector Rank
ROA -44.88%
ROE -58.78%
ROIC N/A
ROA(3y)-35.37%
ROA(5y)-39.2%
ROE(3y)-327.9%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLNE Yearly ROA, ROE, ROICBLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for BLNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLNE Yearly Profit, Operating, Gross MarginsBLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. BLNE Health Analysis

2.1 Basic Checks

  • BLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BLNE has more shares outstanding
  • The number of shares outstanding for BLNE has been increased compared to 5 years ago.
  • The debt/assets ratio for BLNE is higher compared to a year ago.
BLNE Yearly Shares OutstandingBLNE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
BLNE Yearly Total Debt VS Total AssetsBLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • BLNE has an Altman-Z score of -1.30. This is a bad value and indicates that BLNE is not financially healthy and even has some risk of bankruptcy.
  • BLNE's Altman-Z score of -1.30 is on the low side compared to the rest of the industry. BLNE is outperformed by 72.00% of its industry peers.
  • BLNE has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • BLNE has a Debt to Equity ratio of 0.27. This is comparable to the rest of the industry: BLNE outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z -1.3
ROIC/WACCN/A
WACC7.62%
BLNE Yearly LT Debt VS Equity VS FCFBLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

2.3 Liquidity

  • BLNE has a Current Ratio of 1.19. This is a normal value and indicates that BLNE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.19, BLNE is in line with its industry, outperforming 60.00% of the companies in the same industry.
  • BLNE has a Quick Ratio of 1.19. This is a normal value and indicates that BLNE is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.19, BLNE is doing good in the industry, outperforming 62.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
BLNE Yearly Current Assets VS Current LiabilitesBLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. BLNE Growth Analysis

3.1 Past

  • BLNE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.99%, which is quite impressive.
  • Looking at the last year, BLNE shows a very strong growth in Revenue. The Revenue has grown by 33.46%.
  • Measured over the past years, BLNE shows a quite strong growth in Revenue. The Revenue has been growing by 11.40% on average per year.
EPS 1Y (TTM)70.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.71%
Revenue 1Y (TTM)33.46%
Revenue growth 3Y-9.17%
Revenue growth 5Y11.4%
Sales Q2Q%31.42%

3.2 Future

  • BLNE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.04% yearly.
  • The Revenue is expected to grow by 50.32% on average over the next years. This is a very strong growth
EPS Next Y95.64%
EPS Next 2Y38.82%
EPS Next 3Y25.95%
EPS Next 5Y19.04%
Revenue Next Year-0.77%
Revenue Next 2Y-19.09%
Revenue Next 3Y31.14%
Revenue Next 5Y50.32%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BLNE Yearly Revenue VS EstimatesBLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
BLNE Yearly EPS VS EstimatesBLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 0 -100 -200 -300

More info and screens

Find the best growth stocksShow best growing peers

1

4. BLNE Valuation Analysis

4.1 Price/Earnings Ratio

  • BLNE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year BLNE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLNE Price Earnings VS Forward Price EarningsBLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLNE Per share dataBLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60

4.3 Compensation for Growth

  • BLNE's earnings are expected to grow with 25.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.82%
EPS Next 3Y25.95%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BLNE Dividend Analysis

5.1 Amount

  • No dividends for BLNE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLNE Fundamentals: All Metrics, Ratios and Statistics

BEELINE HOLDINGS INC

NASDAQ:BLNE (5/1/2026, 6:06:06 PM)

After market: 1.93 0 (0%)

1.93

+0.16 (+9.04%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Industry Strength39.13
Industry Growth65.22
Earnings (Last)03-31
Earnings (Next)05-18
Inst Owners14.83%
Inst Owner Change2.63%
Ins Owners17%
Ins Owner Change1.34%
Market Cap59.15M
Revenue(TTM)8.25M
Net Income(TTM)-31.51M
Analysts85.71
Price Target4.59 (137.82%)
Short Float %6.63%
Short Ratio2.39
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.48%
Min EPS beat(2)-23.34%
Max EPS beat(2)22.39%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.99%
Min Revenue beat(2)-14.71%
Max Revenue beat(2)6.74%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.17
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 3.82
EV/EBITDA N/A
EPS(TTM)-61.5
EYN/A
EPS(NY)-4.48
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS0.27
BVpS1.75
TBVpS0.5
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -44.88%
ROE -58.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-35.37%
ROA(5y)-39.2%
ROE(3y)-327.9%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.47%
Cap/Sales 6.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z -1.3
F-Score4
WACC7.62%
ROIC/WACCN/A
Cap/Depr(3y)12.62%
Cap/Depr(5y)44.82%
Cap/Sales(3y)4.95%
Cap/Sales(5y)7.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.71%
EPS Next Y95.64%
EPS Next 2Y38.82%
EPS Next 3Y25.95%
EPS Next 5Y19.04%
Revenue 1Y (TTM)33.46%
Revenue growth 3Y-9.17%
Revenue growth 5Y11.4%
Sales Q2Q%31.42%
Revenue Next Year-0.77%
Revenue Next 2Y-19.09%
Revenue Next 3Y31.14%
Revenue Next 5Y50.32%
EBIT growth 1Y-188.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year112.8%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-565.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-564.11%
OCF growth 3YN/A
OCF growth 5YN/A

BEELINE HOLDINGS INC / BLNE Fundamental Analysis FAQ

What is the fundamental rating for BLNE stock?

ChartMill assigns a fundamental rating of 2 / 10 to BLNE.


What is the valuation status for BLNE stock?

ChartMill assigns a valuation rating of 1 / 10 to BEELINE HOLDINGS INC (BLNE). This can be considered as Overvalued.


What is the profitability of BLNE stock?

BEELINE HOLDINGS INC (BLNE) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for BLNE stock?

The Earnings per Share (EPS) of BEELINE HOLDINGS INC (BLNE) is expected to grow by 95.64% in the next year.


How sustainable is the dividend of BEELINE HOLDINGS INC (BLNE) stock?

The dividend rating of BEELINE HOLDINGS INC (BLNE) is 0 / 10 and the dividend payout ratio is 0%.